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Gambian ricketsA relationship between iron and ﬁbroblast growth factor-23 (FGF23) metabolic pathways has been proposed.
Iron deﬁciency anaemia is prevalent in The Gambia and concentrations of ﬁbroblast growth factor-23 FGF23
are elevated in a large percentage of Gambian children with rickets-like bone deformity.
We speculate that low iron status may be involved in the aetiology of Gambian rickets. The aim of this study
was to determine if there was a relationship between haemoglobin, as a marker of iron status, and FGF23 in
samples from children with and without a history of rickets-like bone deformities in The Gambia. We con-
ducted a retrospective analysis of studies carried out from 2006 to 2008 in children from a rural community
in The Gambia where iron deﬁciency anaemia is endemic and where elevated circulating concentrations of
FGF23 have been found. To investigate the relationship between circulating FGF23 and haemoglobin concen-
trations we used an age-adjusted linear regression model on data from children b18 y of age with a family or
personal history of rickets-like bone deformity (BD) (n=108) and from the local community (LC) (n=382).
We found that circulating concentration of FGF23 was inversely correlated with haemoglobin concentration.
This effect was more pronounced in BD children compared with LC children (interaction: P≤0.0001). Anae-
mia and elevated FGF23 were more prevalent in BD children compared to LC children (P=0.0003 and
P=0.0001 respectively).
In conclusion, there is a stronger relationship between FGF23 and haemoglobin in Gambian children with a
history of rickets compared to local community children. This study provides support for the contention
that iron may be involved in FGF23 metabolic pathways.
© 2012 Elsevier Inc. Open access under CC BY license.Introduction
A relationship between iron and FGF23 metabolic pathways has
been proposed [1–4]. A study on a random selection of stored clinical
biochemistry samples has indicated an inverse relationship between
ferritin and FGF23 concentrations [3]. The authors hypothesised that
these results may be highlighting the role of iron in the processing
and excretion of the FGF23 molecule in the kidney [3]. In addition,
a study of autosomal dominant hypophosphataemic rickets (ADHR)
patients and controls indicated a negative relationship between serum
iron and FGF23 concentrations [4]. Furthermore a study of mice with
ADHR has shown that a diet low in iron can induce elevated FGF23 con-
centrations [5].
Studies in children in The Gambia, West Africa have shown that
anaemia is endemic and that iron deﬁciency is the predominant cause
of anaemia throughout the year [6]. A national survey conducted in
2001 indicated that 76% of Gambian children under the age of 5 y had
anaemia, deﬁned as having haemoglobin (Hb) b11.0 g/dl [7]. In addi-
tion, cases of non-vitamin D deﬁciency rickets have been reported inResearch, Elsie Widdowson
7515.
uk (V. Braithwaite).
 license.Gambian children with chronically elevated circulating FGF23 concen-
trations [8]. It has been proposed that a chronically low dietary calcium
supply resulting in a 1,25-dihydroxyvitamin D (1,25(OH)2D)-driven in-
crease in FGF23 concentration and consequent excessive urinary phos-
phate lossmay be contributing to the aetiology of Gambian rickets [8,9].
To investigate the possible link between iron status and FGF23
concentration a post-hoc analysis was conducted on existing data
from previous studies on Gambian children both with and without a
family or personal history of rickets-like bone deformities. Hb was
used as the only available marker of iron status and data collection
was conducted predominantly outside of the malaria season. The
aims of this analysis were to identify any relationship between circu-
lating concentrations of Hb and FGF23, to identify any differences in
this relationship between Gambian children with and without a his-
tory of rickets-like bone deformities and to consider if iron may be
involved in FGF23 metabolic pathways.
Materials and methods
Patients and study design
Existing data were obtained from three studies conducted previ-
ously at MRC Keneba, The Gambia. Written informed consent was
1352 V. Braithwaite et al. / Bone 50 (2012) 1351–1356obtained from parents of children involved in the three studies.
Ethical approval for the original studies and the analysis of existing
data was given by The Gambian Government/MRC Laboratories Joint
Ethics Committee. Data from children under the age of 18.0 y with
no acute illness a week prior to the study and with measurements
for both FGF23 and Hb were included.
Children with a personal or family history of rickets-like bone deformity
(BD children)
Data from 32 of the 35 children with a history of rickets-like bone
deformities (BD Index) as described in [9] and their siblings (n=76)
(BD Siblings) were obtained from an aetiological follow-up study of
rickets in The Gambia and were selected on the basis of ﬁtting the
inclusion criteria (see Patients and study design section). Measure-
ments of these children were made between May–September 2006.
At presentation the BD Index children were characterised by 25-
hydroxyvitamin D (25OHD) concentration in the normal range, ele-
vated FGF23 and 1,25(OH)2D concentrations and a low plasma phos-
phate (P) concentration. The elevations in FGF23 were observed over
a year of treatment with calcium (Ca) and vitamin D as described
in [8]. At follow-up at a mean of 4 y, 16 of the BD Index children
included in these analyses had lasting leg deformities [9].
Children from the local community (LC children)
Data were obtained from two community studies to provide
anthropometry and biochemistry from outwardly healthy children
(LC children) (n=382) who were selected on the basis of ﬁtting the
inclusion criteria (see Patients and study design section). The protocol
for the ﬁrst study (n=74) has been described elsewhere [9]. The
children were measured in January–February (n=26) and September–
October 2007 (n=48). The second study was a follow-up (Jarjou LMA,
and Prentice A, unpublished) of children (n=308) born to mothers
who had previously participated in a Ca supplementation study during
pregnancy (ISRCTN96502494), and who had previously taken part in a
study of blood pressure at ages 5–10 y [10]. These data were collected
from May–October 2007 and April–August 2008.
Anthropometry
Weight was measured to the nearest 0.1 kg using a calibrated elec-
tronic scale (model HD-314, Tanita B.V., Hoofddorp, The Netherlands).
Height was measured to the nearest mm using a portable stadiometer
(Leicester Height Measure, SECA, Hamburg, Germany). Sitting height
was also measured in BD children to the nearest mm using the
same portable stadiometer. Body mass index (BMI) was calculated
by dividing weight (kg) by height2 (m2).
Fasting blood and 2 h urine collection
An overnight-fasted, 2 h urine sample was collected between the
hours of 0700–0900. Acidiﬁed (HCl 10 μl/ml, laboratory reagent
grade SD 1.18, Fisher Scientiﬁc) urine aliquots were stored at
−20 °C and then later transported frozen on dry ice to MRC HNR,
Cambridge, UK where they were stored at −20 °C until analysis.
A fasting, antecubital venous blood sample (5–15 ml according
to the age of the child) was collected 1 h after the start of the 2 h
urine collection and was transferred to pre-cooled lithium–heparin
(LiHep) and ethylenediaminetetraacetic acid (EDTA)-coated tubes.
Blood ionised Ca (iCa) and Hb were measured in whole blood
(ABL77, Radiometer Medical, MA, USA) within 10 min, and pH 7.4
corrected values for iCa were used. The remainder of the blood was
separated by centrifugation at 4 °C within 45 min and frozen at
−70 °C, and later transported frozen on dry ice to MRC HNR where
it was stored at −80 °C until analysis.
Biochemical analysis
The samples were analysed for markers of vitamin D, Ca and P
metabolism and of renal function, using commercially-availablemethods according to the manufacturers' instructions. EDTA-plasma
was used for the analysis of intact parathyroid hormone (PTH) and
C-terminal FGF23; LiHep-plasma was used for other analyses. PTH
was measured by immunoradiometric assay (DiaSorin Ltd, UK) and
FGF23 was analysed using a 2nd generation C-terminal, two-site
enzyme-linked immunosorbant assay (Immutopics Inc.,CA, USA).
For FGF23 the manufacturer's upper limit of the reference range of
125 RU/ml was used as a cut-off of normality and >1000 RU/ml was
considered grossly elevated. Plasma 25OHD and 1,25(OH)2D were
measured by radioimmunoassay (DiaSorin, Stillwater, MN, USA and
IDS, UK respectively). For 25OHD, b25 nmol/l was taken as an indica-
tor of increased risk of vitamin D-deﬁciency rickets [11]. The follow-
ing colorimetric methods (Koni Analyser 20i, Finland) were used to
determine plasma analytes: P, ammonium molybdate; albumin, bro-
mocresol purple; total alkaline phosphatase (TALP), p-nitrophenol
and cystatin C (Cys C), immunoprecipitation. Acidiﬁed urine was
used to determine urinary (u) P, Ca and creatinine (Cr) employing
the same colorimetric methods as for plasma P, the arsenazo III meth-
od for uCa and the Jaffe method for uCr. Standards used in urinary
assays were acidiﬁed prior to use. Assay accuracy and precision
were monitored across the working range of the assays using refer-
ence materials provided by external quality assurance schemes
(National-external-quality-assessment-scheme (NEQAS), Depart-
ment of Clinical Biochemistry, Royal Inﬁrmary, Edinburgh, UK: Vita-
min D-external-quality-assessment-scheme (DEQAS), Endocrine/
Oncology Laboratory, Charing Cross Hospital, London, UK) or pur-
chased commercially (Radiometer Medical, MA, USA and Roche
Human Control, Roche Diagnostics Ltd, UK) and kit controls supplied
by the manufacturer. In addition, an aliquot of a pooled plasma sam-
ple was assayed in each batch to monitor possible drift over time and
to provide running quality assurance for analytes where no external
reference material was available.
Statistical analysis and calculations
Multiple regression tests were performed using DataDesk 6.1
(Data Description Inc., NY, USA) and two-tailed Chi-square tests
(without Yates' correction) were performed using GraphPad Quick-
Calcs (GraphPad Software, Inc.). Normally distributed data are pre-
sented as mean (1SD), positively skewed distributions of data are
presented as geometric mean (−1SD, +1SD) obtained from the anti-
log of mean (1SD) for the logged values. Variables with positively
skewed distributions were transformed to natural logarithms before
further statistical analysis.
Regression analysis was used to assess the relationships between
age (as a continuous variable), group, and sex with each variable
(anthropometric or biochemical). To determine differences in
the relationships between variables and group (BD Index vs. BD Si-
bling, BD vs. LC, anaemic vs. non-anaemic or FGF23>125 RU/ml vs.
FGF23≤125 RU/ml) an interaction term (group×independent vari-
able) was used in the model as an independent variable. Sex was
not found to be a signiﬁcant factor in predicting any of the variables,
and therefore was not included in the models presented in this paper.
However, weight, height, BMI, 25OHD, iCa, P, TALP, Hb, FGF23,
1,25(OH)2D, PTH, uP:uCr and tubular maximal reabsorption of phos-
phate (TmP:GFR) were inﬂuenced by age. Age, therefore, was added
as an independent variable in regression models and age-adjusted
data have been used throughout the text and in the tables. In addi-
tion, age-adjusted FGF23 and Hb values were calculated to explore
the relationship further. Age-adjustment for Hb was derived by in-
cluding logeHb and age in the regression model separately for each
group (BD or LC); evaluating the residual for each subject; adding
the residual to loge (mean group Hb) value; and calculating the anti-
log. Age-adjusted FGF23 was derived using the same method.
Children were deﬁned as being anaemic based on Hb thresholds
fromUK Scientiﬁc Advisory Committee onNutrition (SACN) guidelines:
5–11.99 y≤11.5 g/dl, 12–14.99 y (and non-pregnant females>15 y)
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were seen in the FGF23 or Hb measurements and therefore season
was not incorporated into any analyses.
Estimated glomerular ﬁltration rate (eGFR) ml/min, was derived by
eGFR=[74.835/(Cys C(mg/l)1/0.75)] ml/min [13]. TmP:GFR (mmol/l)
was determined in the following way: tubular reabsorption of
phosphate (TRP)=1−{(uP/P)×(Cr/uCr)}, if TRPb0.86 then TmP:
GFR=TRP×P mmol/l, if TRP>0.86 then TmP:GFR=(0.3×TRP/
{1−(0.8×TRP)})×P mmol/l [14]. uP and uCa were expressed as a
molar ratio with uCr (uP:uCr and uCa:uCr respectively).Results
Characterisation of BD and LC children
The children as a whole (n=490) had a mean age of 8.9 (3.0) y
and 51% were female. When looking at the children with a personal
or a family history of rickets-like bone deformities (BD) there was
no difference between Index children (n=32) or their siblings
(n=76) in any variables before and after age-adjustments were
made, with the exception of height where the BD siblings tended to
be taller than the index children (P=0.03) (data not shown.). There
was no signiﬁcant difference in age or sex ratio between BD children
(n=108) and the children from the local community (LC) (n=382)
(Table 1). The children from both groups were not signiﬁcantly differ-
ent in height but the BD children were heavier and had a greater
BMI compared to LC children after adjusting for age (P≤0.0001 and
P ≤0.0001 respectively). This difference was unlikely to be fully
accounted for by the lasting leg deformities in some of the BD Index
children; there was a strong correlation between sitting and standing
height (R2=98.0%). In addition the difference between BMI in BD
and LC remained when BD Index children with lasting leg deformities
were excluded (P≤0.0001).Table 1
Data from children with a personal or family history of rickets-like bone deformities (BD) a
Dependent BD children L
Variable n=108 n
Characteristics
Age (y) 8.7 (4.5) 8
Sex (F/M) 52/56 1
Height (m) 1.23 (0.3) 1
Weight (kg) 26.5 (13.7) 2
BMI (kg/m2) 16.0 (2.5) 1
Biochemistry
iCa (7.4) (mmol/l) 1.13 (0.05) 1
25OHD (nmol/l) 62.5 (14.7) 6
1,25(OH)2D* (pmol/l) 262.9 (184.5, 374.5) 2
PTH* (pg/ml) 49.9 (28.6, 87.2) 5
P (mmol/l) 1.51 (0.22) 1
FGF23* (RU/ml) 77.9 (19.5, 310.8) 6
TALP* (U/l) 293 (204, 421) 2
Cys C (mg/l) 0.83 (0.12) 0
Hb* (g/dl) 12.8 (11.6, 14.1) 1
Albumin (g/l) 39.5 (3.6) 3
eGFR and mineral excretion
eGFR* (ml/min) 96.6 (79.9, 117.0) 1
TmP:GFR (mmol/l) 1.67 (0.32) 1
uP:uCr* 1.69 (0.97, 2.95) 1
uCa:uCr* 0.07 (0.02, 0.26) 0
For normally distributed data, the results are mean (SD); for positively skewed data (denote
P-value (BD children=1, LC children=0) were determined by regression analysis or from c
inal units for normally distributed data and as a proportion for skewed data.Biochemical proﬁle of BD and LC children
All of the children, with the exception of n=2 LC children, had a
plasma 25OHD concentration above 25 nmol/l but there was no sig-
niﬁcant difference in mean 25OHD concentration between BD and
LC children. BD children had higher 1,25(OH)2D, and lower Hb than
LC children (P≤0.0001 and P=0.0006 respectively). uP:uCr, and
uCa:uCr were higher, and TmP:GFR was lower in BD children than
in LC children (P≤0.0001, P=0.009, and P=0.0007 respectively). Cys
C tended to be higher and eGFR was lower in BD children than in LC
(P=0.02 and P=0.03 respectively). Albuminwas higher in BD children
than in LC children (P=0.01) and there was no signiﬁcant difference in
plasma iCa and P concentration between the groups (Table 1).
Anaemia
The prevalence of anaemia was higher in BD children compared
with LC children (15% vs. 6%, χ2=8.2, P=0.0004). Anaemic children
were younger than non-anaemic children (P=0.006). After adjusting
for age, anaemic children (n=40) tended to be shorter, and heavier
and had a greater BMI than non-anaemic children (n=450)
(P=0.02, P=0.02 and P=0.006 respectively) (Table 2). Plasma
FGF23 and 1,25(OH)2D concentrations were higher in children with
anaemia compared to those without (P≤0.0001 and P=0.03 respec-
tively). There was no signiﬁcant difference in 25OHD or PTH between
the two groups but iCa was higher in the anaemic children
(P=0.007). TmP:GFR tended to be lower and uCa:uCr was higher in
anaemic children compared to non-anaemic children (P=0.04 and
P=0.0003 respectively) but there was no difference in eGFR or in
plasma P. Albumin was lower in anaemic children compared to
those without (P≤0.0001).
Predictors of elevated FGF23 concentrations
27% of BD children (n=29) had circulating concentrations of
FGF23 above the upper limit of normal (>125 RU/ml) compared to
13% of LC children (n=48) (χ2=12.9, P=0.0003). 8% of BD childrennd children from the local community (LC).
C children Difference P-value
=382 Age-adjusted
.9 (2.4) −0.3 0.4
99/183 – 0.5
.26 (0.1) −0.01 0.14
3.6 (6.8) 3.3 0.0001
4.6 (1.5) 1.4 0.0001
.13 (0.05) −1.8x10−8 0.9
1.8 (15.8) 0.6 0.7
17.3 (160.9, 293.3) 0.2* 0.0001
4.7 (34.3, 87.4) −1.2* 0.2
.48 (0.18) 0.2 0.3
5.5 (30.9, 138.4) 0.1* 0.12
91 (229, 368) 0.005* 0.9
.80 (0.12) 0.03 0.02
3.3 (12.0, 14.7) −0.04* 0.0006
8.7 (2.9) 0.8 0.01
01.4 (83.5, 123.1) −0.05* 0.03
.77 (0.26) −0.1 0.0007
.20 (0.64, 2.26) 0.33* 0.0001
.05 (0.01, 0.18) 0.37* 0.009
d by *) the results are geometric mean (−1SD, +SD). The age-adjusted difference and
hi-square (for sex); age and sex were un-adjusted. The difference is expressed in orig-
Table 2
Data from children with and without a personal or family history of rickets-like bone deformities (BD and LC) with and without anaemia.
Dependent Anaemic Non-anaemic Difference P-value
Variable n=40 n=450 Age-adjusted
Characteristics
Age (y) 7.66 (4.31) 9.0 (2.83) −1.3 0.006
Sex (F/M) 21/19 230/220 – 0.9
Height (m) 1.16 (0.26) 1.26 (0.16) −0.02 0.02
Weight (kg) 22.5 (13.7) 24.4 (8.32) 1.7 0.02
BMI (kg/m2) 15.3 (2.4) 14.9 (1.8) 0.8 0.006
Biochemistry
iCa (7.4) (mmol/l) 1.15 (0.04) 1.26 (0.05) 0.02 0.007
25OHD (nmol/l) 65.1 (19.9) 61.7 (15.1) 2.6 0.3
1,25(OH)2D* (pmol/l) 256.7 (182.2, 361.5) 224.0 (162.9, 308.1) 0.1* 0.03
PTH* (pg/ml) 53.9 (37.2, 78.0) 53.8 (32.7, 88.4) 0.6* 0.6
P (mmol/l) 1.46 (0.20) 1.49 (0.19) −0.05 0.08
FGF23* (RU/ml) 157.2 (32.6, 758.9) 63.2 (28.1, 141.8) 0.8* 0.0001
TALP* (U/l) 270.4 (187.8, 389.3) 293.1 (226.4, 379.4) −0.09* 0.02
Cys C (mg/l) 0.81 (0.12) 0.81 (0.11) 0.01 0.5
Hb* (g/dl) 10.8 (9.9, 11.8) 13.4 (12.4, 14.5) −0.2* 0.0001
Albumin (g/l) 36.9 (4.1) 39.1 (2.9) −2.1 0.0001
eGFR and mineral excretion
eGFR* (ml/min) 98.6 (78.7, 123.4) 100.5 (83.0, 121.7) −0.01* 0.7
TmP:GFR (mmol/l) 1.68 (0.31) 1.76 (0.3) −0.09 0.04
uP:uCr* 1.61 (0.99, 2.61) 1.27 (0.67, 2.40) 0.17* 0.10
uCa:uCr* 0.11 (0.04, 0.34) 0.05 (0.01, 0.18) 0.77* 0.0003
For normally distributed data, the results are mean (SD); for positively skewed data (denoted by *) the results are geometric mean (−1SD, +SD). The age-adjusted difference and
P-value (anaemic=1, non-anaemic=0) were determined by regression analysis or from chi-square (for sex); with the exception of age and sex which were un-adjusted. The dif-
ference is expressed in original units for normally distributed data and in proportion for skewed data.
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pared with 2% of LC children (n=2) (χ2=11.3, P=0.0008). There
was no difference in the number of BD Index or BD Sibling childrenTable 3




Age (y) 6.65 (3.69)
Sex (F/M) 43/34
Height (m) 1.10 (0.24)
Weight (kg) 19.4 (9.7)
BMI (kg/m2) 15.0 (1.6)
Biochemistry
iCa (7.4) (mmol/l) 1.13 (0.05)
25OHD (nmol/l) 62.7 (17.2)
1,25(OH)2D* (pmol/l) 264 (192, 362)
PTH* (pg/ml) 53.6 (30.7, 93.3)
P (mmol/l) 1.52 (0.23)
FGF23* (RU/ml) 379.3 (152.6, 942.4)
TALP* (U/l) 304 (224, 414)
Cys C (mg/l) 0.84 (0.13)
Hb* (g/dl) 12.3 (10.8, 14.0)
Albumin (g/l) 38.7 (3.4)
eGFR and mineral excretion
eGFR* (ml/min) 95.2 (77.8, 116.4)
TmP:GFR (mmol/l) 1.72 (0.35)
uP:uCr8* 1.66 (0.85, 3.24)
uCa:uCr* 0.08 (0.02, 0.33)
For normally distributed data, the results are mean (SD); for positively skewed data (denote
P-value (FGF23>125=1 and FGF23≤125=0) were determined by regression analysis or
The difference is expressed in original units for normally distributed data and in proportion
niﬁcantly heavier than FGF23≤125 which is why the difference is +0.03.with concentrations of FGF23>125 or >1000 RU/ml (P=0.1 and
P=0.2 respectively). Children with high FGF23 were younger
than children with FGF23 within the normal range (P=0.0001)mities (BD and LC) divided by FGF23 concentration.
FGF23≤125 Difference P-value
n=413 Age-adjusted
9.32 (2.66) −2.7 0.0001
208/205 – 0.4
1.28 (0.14) −0.04 0.0001
25.2 (8.4) 1.3 0.03
14.9 (1.9) 0.9 0.0001
1.13 (0.05) 0.0005 0.4
61.8 (15.3) −0.9 0.6
220.2 (160, 303) 0.1 0.0002
53.8 (33.5, 86.6) 1.3* 0.2
1.48 (0.18) −0.009 0.7
49.4 (31.1, 78.4) 1.9* 0.0001
289 (223, 375) 0.02* 0.6
0.80 (0.11) 0.04 0.02
13.3 (12.2, 14.6) −0.06* 0.0001
38.9 (3.1) −0.4 0.4
101.4 (83.7, 122.7) −0.06* 0.02
1.76 (0.26) −0.07 0.05
1.24 (0.67, 2.28) 0.19* 0.02
0.05 (0.02, 0.18) 0.4* 0.02
d by *) the results are geometric mean (−1SD, +SD). The age-adjusted difference and
from chi-square (for sex); with the exception of age and sex which were un-adjusted.
for skewed data. NB. When adjusted for age the children with FGF23>125 were sig-
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FGF23 (>125 RU/ml) were shorter, tended to be heavier and had a
greater BMI than children with FGF23 concentrations within the
normal range (P≤0.0001, P=0.03 and P≤0.0001 respectively)
(Table 3). 1,25(OH)2D and Cys C were higher in children with high
FGF23 (P=0.0002 and P=0.02 respectively) and Hb was lower
(P≤0.0001). eGFR and TmP:GFR were lower, and uP:uCr and uCa:
uCr were higher in children with high FGF23 concentrations com-
pared to those with FGF23 within the normal range (P=0.02,
P=0.05, P=0.02 and P=0.02 respectively). There was no signiﬁcant
difference in iCa, 25OHD, PTH, P, TALP or albumin between the two
groups.
In univariate regression models the dependent variable
logeFGF23 was negatively associated with logeHb, logeTALP, logeeGFR,
height and weight (logeHb: coefﬁcient=−2.54(SE 0.39), t-ratio=
−6.41, P≤0.0001, R2=7.6%; logeTALP: coefﬁcient=−0.47(SE 0.15),
t-ratio=3.09, P=0.002, R2=1.7%; logeeGFR: coefﬁcient=−0.46(SE
0.21), t-ratio=−2.15, P=0.03, R2=0.7%, height: coefﬁcient=
−2.08(SE 0.21), t-ratio=−9.58, P≤0.0001, R2=15.7%; and weight:
coefﬁcient=−0.03(SE 0.004), t-ratio=−6.51, P≤0.0001,R2=7.9%)
and positively associated with loge1,25(OH)2D, cystatin C and logeuP:
uCr (loge1,25(OH)2D: coefﬁcient=0.52(SE 0.12), t-ratio=4.14,
P≤0.0001, R2=3.2%; cystatin C: coefﬁcient=0.78(SE 0.35), t-ratio=
2.25, P=0.02, R2=0.8%; and logeuP:uCr: coefﬁcient=0.23(SE 0.06),
t-ratio=3.66, P=0.0003, R2=2.5%). In a multivariate regression
model with the dependent variable logeFGF23 against all of the signiﬁ-
cant independent variables from univariate analysis logeHb and height
were the two strongest predictors of logeFGF23.
FGF23 and haemoglobin
Hb was a strong independent negative predictor of FGF23 con-
centration after adjusting for age; the coefﬁcient for logeHb=
−1.77(SE 0.40), t-ratio=−4.48, P≤0.0001 (Fig. 1). This effect, how-
ever, was more pronounced in BD children (coefﬁcient=−4.28 (SEFig. 1. Relationship between age-adjusted haemoglobin (Hb) (g/dl) and age-adjusted FGF23
children (local community) ▿. Age-adjusted Hb was derived by including loge Hb and age in
each subject; adding the residual to loge (mean group Hb) value; and calculating the antilo
line derived frommultiple regression using unadjusted loge FGF23 (y) with unadjusted logeH
(logeHb)]− [0.08 (SE 0.03) (age)], R2=23.2%, P=0.001 and LC children only was logeFGF
P=0.005. All) both BD and LC children together was logeFGF23=[9.59 (SE 0.99)]− [1.77
The logeHb×group interaction was highly signiﬁcant (Pb0.0007) demonstrating difference1.27), t-ratio=−3.37, P=0.001) compared to LC children (coefﬁ-
cient=−1.08 (SE 0.38), t-ratio=−2.84, P=0.005) (Fig. 1). Further-
more the age-adjusted relationship between FGF23 and Hb was
different in BD and LC children (test for interaction P=0.0007).
When excluding the two LC children with Hb concentrations lower
than 9 g/dl, the age-adjusted relationship between FGF23
and Hb in LC children was no longer present (P=0.2). However, the
group interaction term (BD vs.LC) was still signiﬁcant (P≤0.0001).
There was no signiﬁcant difference in the relationship between Hb
and FGF23 in BD Index and BD Sibling children (P=0.01 and
P=0.03 respectively, test for interaction: P=0.5); BD Index log-
eFGF23=[18.65(SE 5.6)]− [5.82(SE 2.21)(logeHb)]− [0.04(SE
0.09)(age)] and BD Sibling logeFGF23=[14.3(SE 3.82)]− [3.47(SE
1.54)(logeHb)]− [0.10(SE 0.03)(age)]. The FGF23 vs. Hb correlation
and the signiﬁcant group interaction were not materially different in
multiple regression models that also included weight, height and al-
bumin to account for any confounding due to differences in nutritional
status. In these models weight and height were signiﬁcant predictors
of FGF23 in addition to Hb (positive and negative respectively), but
age and albumin were not (data not shown).
Discussion
This study has demonstrated an inverse relationship between Hb
and FGF23 concentrations which is in keeping with other reports sug-
gesting a link between iron status and FGF23 metabolism. These
include Durham et al. with ferritin and FGF23 concentrations [3],
Imel et al. with serum iron and FGF23 concentrations [4] and Farrow
et al. showing that a diet low in iron can induce elevated FGF23 con-
centrations in an ADHRmouse model [5]. The inverse relationship be-
tween Hb and FGFG23 was apparent when the data were examined as
a whole but the magnitude of the negative slope was signiﬁcantly dif-
ferent between BD and LC children, being steeper in the BD children.
Once the more severely anaemic LC children were excluded there was(RU/ml) (on a logarithmic scale) grouped into BD children (bone deformity) ▴ and LC
the regression model separately for each group (BD or LC); evaluating the residual for
garithm. Age-adjusted FGF23 was derived using the same method. The equation of the
b and age (x) for: BD children only was logeFGF23=[16.05 (SE 3.16)]− [4.28 (SE 1.27)
23=[7.69 (SE 0.95)]− [1.08 (SE 0.38) (logeHb)]− [0.08 (SE 0.01) (age)], R2=10.4%,
(SE (0.40) (logeHb)]− [0.09 (SE 0.01) (age)], R2=15.5%, P≤0.0001 (line not shown).
s between BD and LC in the slopes of the relationship.
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dren; however, the group difference in the relationship remained.
To our knowledge, the data from LC children represent one of the
largest sets of FGF23 concentrations from a healthy, although gener-
ally undernourished, paediatric population living in a low-income
country. One of the interesting ﬁndings from this study was that
FGF23 was not only elevated in children with a personal or family his-
tory of rickets-like bone deformities but also, albeit to a lesser extent,
in some apparently healthy children living in the local community.
13% of LC children had FGF23 concentrations over the upper
limit of normal (>125 RU/ml) compared with 27% of BD children.
Furthermore 2% of LC children had FGF23 concentrations over
1000 RU/ml, which are concentrations generally only reported in pa-
tients with clinical pathologies such as hereditary hypophosphatemic
rickets and chronic kidney disease [15]. Another interesting ﬁnding is
that unaffected siblings of children with a history of rickets-like bone
deformities had biochemical proﬁles more similar to their affected
siblings than to children from the local community. This suggests
genetic factors and/or the household environment may be con-
tributing to these results.
One of the consistent results in this study and our previous studies
[9] is a possible involvement of the kidney in the aetiology of
Gambian rickets. The BD and LC children with elevated FGF23 have
lower eGFR albeit within the normal range. In addition the BD chil-
dren were shorter, heavier and had a higher BMI than LC children.
This ﬁnding remained even after the BD Index children with lasting
leg deformities were excluded.
The C-terminal ELISA kit (Immutopics) was used to determine the
circulating concentrations of FGF23. This assay can detect both the bi-
ologically active, intact FGF23 hormone and the biologically inactive
C-terminal FGF23 fragment [16]. Researchers have hypothesised
that iron may act on FGF23 pathways in the following ways; ﬁrstly
by inhibiting the cleavage of the intact FGF23 molecule and secondly
in assisting the clearance of FGF23 fragments by the kidney [3]. It
is possible that a low eGFR could result in an accumulation of C-
terminal FGF23 fragments and would thus contribute to a greater
amount of FGF23 detected by the assay. However, the lower TmP:
GFR in BD children and, therefore greater urinary phosphate excre-
tion, indicates the presence of biologically active and intact FGF23.
Thus the FGF23 that we have detected is likely to be predominantly
the biologically functional, intact FGF23 molecule which is decreasing
phosphate reabsorption in the renal tubules. However, despite a
higher FGF23 concentration and associated greater urinary phosphate
excretion, the BD children showed no signs of hypophosphatemia.
The ability of Gambian children, in general, to maintain normopho-
sphatemia in the face of an elevated FGF23 concentration may be
explained by the low Ca-to-P ratio of the Gambian diet which
would be expected to result in enhanced intestinal absorption of P,
as we have described elsewhere [9].
Iron deﬁciency and malaria are the two major causes of anaemia
in The Gambia [6,17]. Iron deﬁciency is the predominant cause for
anaemia throughout the year [6] whereas the majority of malarial
anaemia is seen during the months of September–December [18].
84% of all children in this study and 68% of anaemic children were
measured outside of September–October. Only n=2 BD children
were measured during the malaria season. Although we cannot dis-
count the possibility that Hb was marking underlying traits such as
sickle-cell anaemia or thalassemia, the results from this study there-
fore suggest that, although direct markers of iron status were not
measured, it is likely that Hb concentration was an indicator of iron
status in more than 70% of children with anaemia.Therefore, in conclusion this study supports the contention that
iron is involved in FGF23 metabolic pathways. Furthermore it has
shown that this effect is more pronounced in children with a personal
or family history of rickets-like bone deformities. It has been pro-
posed that rickets in The Gambia is predominantly caused by a chron-
ically low dietary calcium supply leading to increased FGF23, and
associated urinary phosphate loss [8,9]. It is possible that poor iron
status may also play a role in the elevation of FGF23 concentrations
and therefore may be a contributing factor to Gambian rickets.
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